Get a pulse on the US markets on Tuesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
TAMPA, FL / ACCESS Newswire / March 25, 2026 / Thunder Rock Capital LLC ("Thunder Rock Capital"), a leading investment banking firm specializing in M&A, capital markets, and structured products, served as exclusive M&A advisor to Neuritek Therapeutics, Inc. in connection with its proposed sale to Wellgistics Health, Inc. (Nasdaq:WGRX) (the "Transaction"), pursuant to which Wellgistics is expected to acquire substantially all of the assets and operations of Neuritek, a U.S.-based healthcare technology company focused on next-generation neurological and cognitive health solutions.
TAMPA, FL / ACCESS Newswire / March 19, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that its President and Interim Chief Executive Officer, Prashant Patel, together with an additional participant from the Company's Board of Directors, entered into agreements with the Company to convert an aggregate of approximately $2.0 million of accrued compensation into shares of the Company's common stock at a conversion price of $0.20 per share, representing a premium to the Company's recent trading price. In connection with the conversion, the Company will issue approximately 10,000,000 shares of common stock.
TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that its President & Interim-CEO Prashant Patel, RPh released a letter to shareholders.
Medical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoption
The prescription drug market still runs through three gatekeepers— CVS Caremark (NYSE: CVS), Cigna’s Express Scripts (NYSE: CI) , and UnitedHealth’s OptumRx (NYSE: UNH) —but the regulatory vise has squeezed out their most profitable practices. The stocks have already taken a beating but might go lower unless they take action now. This disruption in the market creates an opening for alternatives. Wellgistics Health (NASDAQ: WGRX) is building a blockchain and smart‑contract platform designed to monetize prescription flows without relying on the opaque spread pricing and rebate games now under attack. They have exactly what the PBMs need after this crackdown. Additionally, through their partner DataVault, they have the IP to usher in a true digital prescription that cannot be tampered with and contains its own audit trail.
Datavault AI (NASDAQ: DVLT) and Wellgistics Health Inc. (NASDAQ: WGRX) announced plans to expand their existing blockchain-enabled smart contracts partnership beyond prescription tracking to support Wellgistics’ emerging Healthcare as a Service model. The expanded collaboration will integrate additional Datavault AI intellectual property into Wellgistics’ EinsteinRx(TM) and PharmacyChain(TM) platforms to enable secure data integration from pharmacies, hospitals, clinics, diagnostic labs, telehealth providers, wearables and insurers, supporting a hub-and-spoke prescription delivery model and a comprehensive app-based patient engagement solution designed to improve outcomes while reducing total cost of care.
The global blockchain in healthcare market is projected to grow from $11 billion in 2024 to $214 billion by 2030, with annual growth rates expected to exceed 60%
Previously announced partnership with Tollo Health subsidiary TolloCare adding telehealth service offering to drive Wellgistics Pharmacy prescription drug dispending of GLP-1 drugs and promote patient engagement via mental health AI software solution for compliance and to promote lifestyle changes
Tollo Health recently formed subsidiary TolloCare, LLC ('TolloCare') initially targeted to provide telehealth services for GLP-1 and Long COVID patients
Wellgistics Health to leverage EinsteinRx™ AI pharmacy hub and PharmacyChain™ smart contracts to drive healthcare optimization for former NFL players that and rural communities
ATLANTIC CITY, NJ / ACCESS Newswire / January 23, 2026 / DealFlow Events today announced the growing list of companies scheduled to present and participate in one-on-one meetings with investors and analysts at the DealFlow Discovery Conference, taking place January 28-29, 2026, at the Borgata Hotel Casino & Spa in Atlantic City.
Feasibility assessment completed, PharmacyChain™ to leverage Datavault AI's edge network and quantum key encryption to improve data driven outcomes in $634 billion prescription drug market
